Erratum to: Post-transcriptional silencing of Notch2 mRNA in chronic lymphocytic leukemic cells of B-CLL patients

被引：0
|
作者：
Kaneez Fatima
Rehan Zafar Paracha
Ishtiaq Qadri
机构：
[1] National University of Sciences and Technology (NUST),NUST Centre of Virology and Immunology (NCVI)
[2] Quaid-e-Azam University,Biotech Park Faculty of Biological Sciences
来源：
Molecular Biology Reports | 2012年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7839 / 7839
相关论文
共 50 条
  • [41] Induction of an immunogenic and apoptotic phenotype in B chronic lymphocytic leukemia (B-CLL) cells by immunostimulatory PyNTTTTGT oligodeoxynucleotides (ODN).
    Dupont, J
    Flo, J
    Zorzopulos, J
    Riveros, D
    Lopez, R
    Garay, G
    Cacchione, R
    BLOOD, 2003, 102 (11) : 429A - 430A
  • [42] Expanded subsets of circulating CD38+T cells in B cell chronic lymphocytic leukemia [B-CLL]
    Bjork, RL
    Mcdaniel, PR
    Saven, A
    Bjork, RL
    CYTOMETRY, 2002, : 107 - 107
  • [43] Mean telomere length and telomerase activity of peripheral blood cells from patients with B-cell chronic lymphocytic leukemia (B-CLL).
    Tsilika, A
    Pappa, VI
    Taffas, T
    Chalevelakis, G
    Kontsioti, F
    Psara, E
    Economopoulos, T
    Papageorgiou, E
    Dervenoulas, J
    Kapsimali, V
    Pappa, M
    Rapis, S
    Skandalis, A
    BLOOD, 1999, 94 (10) : 538A - 538A
  • [44] Expansion of CMV-specific CD8+ T cells in patients with B-cell chronic lymphocytic leukemia (B-CLL)
    Pourgheysari, B
    Bruton, R
    Khan, N
    Moss, PAH
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 26 - 26
  • [45] The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia (B-CLL) is decreased by thalidomide and fludarabine treatment
    Giannopoulos, K.
    Schmitt, M.
    Wlasiuk, P.
    Chen, J.
    Bojarska-Junak, A.
    Kowal, M.
    Rolinski, J.
    Dmoszynska, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 190 - 190
  • [46] Derivation of expanded killer cells from patients with B-chronic lymphocytic leukemia (B-CLL): A potential source for cellular immunotherapy.
    Guven, H
    Gilljam, M
    Chambers, BJ
    Ljunggren, HG
    Christensson, B
    Kimby, E
    Dilber, MS
    BLOOD, 2002, 100 (11) : 595A - 595A
  • [47] Reduced intensity conditioning in patients with B-chronic lymphocytic leukaemia (B-CLL):: results of a prospective multicentre trial
    Caballero, D
    Martino, R
    Mateos, M
    León, A
    Urbano, A
    Sanz, G
    Sarrá, J
    Simón, JP
    Valcarcel, D
    Sureda, A
    Sierra, J
    San Miguel, J
    BONE MARROW TRANSPLANTATION, 2004, 33 : S110 - S110
  • [48] Expression of bone morphogenetic proteins (BMPs) receptors in patients with B-cell chronic lymphocytic leukemia (B-CLL)
    Dzietczenia, J.
    Wrobel, T.
    Jazwiec, B.
    Mazur, G.
    Butrym, A.
    Poreba, R.
    Kuliczkowski, K.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2010, 32 (06) : E217 - E221
  • [49] In vitro and in vivo cytotoxicity of fludarabine in patients with advanced stage B-cell chronic lymphocytic leukemia (B-CLL)
    Hilgenfeld, E
    Knauf, WU
    Thiel, E
    DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA II, 1997, 3 : 245 - 253
  • [50] Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients:: impact on clonal B-cell apoptosis
    Kay, NE
    Han, L
    Bone, N
    Williams, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 760 - 767
12345